- Home
- PSO vs BRKR Comparison
PSO vs BRKR Comparison
Compare PSO & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSO
- BRKR
- Stock Information
- Founded
- PSO 1844
- BRKR 1960
- Country
- PSO United Kingdom
- BRKR United States
- Employees
- PSO N/A
- BRKR N/A
- Industry
- PSO Books
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- PSO Consumer Discretionary
- BRKR Industrials
- Exchange
- PSO Nasdaq
- BRKR Nasdaq
- Market Cap
- PSO 10.8B
- BRKR 6.3B
- IPO Year
- PSO 2000
- BRKR 2000
- Fundamental
- Price
- PSO $14.55
- BRKR $41.49
- Analyst Decision
- PSO
- BRKR Buy
- Analyst Count
- PSO 0
- BRKR 12
- Target Price
- PSO N/A
- BRKR $54.50
- AVG Volume (30 Days)
- PSO 650.5K
- BRKR 2.4M
- Earning Date
- PSO 01-01-0001
- BRKR 08-05-2025
- Dividend Yield
- PSO 2.18%
- BRKR 0.47%
- EPS Growth
- PSO 20.49
- BRKR N/A
- EPS
- PSO 0.79
- BRKR 0.52
- Revenue
- PSO $4,446,837,010.00
- BRKR $3,446,100,000.00
- Revenue This Year
- PSO $3.66
- BRKR $6.43
- Revenue Next Year
- PSO $3.94
- BRKR $4.21
- P/E Ratio
- PSO $17.31
- BRKR $80.70
- Revenue Growth
- PSO N/A
- BRKR 14.84
- 52 Week Low
- PSO $12.83
- BRKR $34.10
- 52 Week High
- PSO $17.90
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- PSO 39.87
- BRKR 60.72
- Support Level
- PSO $14.44
- BRKR $41.21
- Resistance Level
- PSO $14.91
- BRKR $43.66
- Average True Range (ATR)
- PSO 0.16
- BRKR 1.60
- MACD
- PSO 0.04
- BRKR 0.20
- Stochastic Oscillator
- PSO 40.91
- BRKR 80.80
About PSO Pearson Plc
Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.